Evidence map›Paper›PMID 38474024›Full record

ArticleInternational journal of molecular sciences2024

Transcriptomic Signatures of Neuronally Derived Extracellular Vesicles Reveal the Presence of Olfactory Receptors in Clinical Samples from Traumatic Brain Injury Patients.

Manish Bhomia, Yanru Feng, Piper Deleon, Claudia S Robertson, Firas Kobeissy, Kevin K Wang, Barbara Knollmann-Ritschel

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. ICAM-5: A Novel Marker for Neuronally Derived Extracellular Vesicles.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Manish BhomiaDepartment of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.ORCID 0000-0003-2808-9927
Yanru FengDepartment of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Piper DeleonDepartment of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Claudia S RobertsonDepartment of Neurosurgery, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-8509-678X
Firas KobeissyDepartment of Neurobiology, Morehouse School of Medicine, Atlanta, GA 30310, USA.ORCID 0000-0002-5008-6944
Kevin K WangDepartment of Neurobiology, Morehouse School of Medicine, Atlanta, GA 30310, USA.
Barbara Knollmann-RitschelDepartment of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Henry M. Jackson Foundation · USMorehouse School of Medicine · USBaylor College of Medicine · USUniformed Services University of the Health Sciences · US

Funding

Characterization of neuronal derived exosomes to detect biomarkers for neurodegenerative disordersR21NS116710 · NINDS · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BHOMIA, MANISH · 2020 to 2020
$422k
NINDS NIH HHS R21 NS116710
6 · The paper itself

Abstract

Traumatic brain injury (TBI) is defined as an injury to the brain by external forces which can lead to cellular damage and the disruption of normal central nervous system functions. The recently approved blood-based biomarkers GFAP and UCH-L1 can only detect injuries which are detectable on CT, and are not sensitive enough to diagnose milder injuries or concussion. Exosomes are small microvesicles which are released from the cell as a part of extracellular communication in normal as well as diseased states. The objective of this study was to identify the messenger RNA content of the exosomes released by injured neurons to identify new potential blood-based biomarkers for TBI. Human severe traumatic brain injury samples were used for this study. RNA was isolated from neuronal exosomes and total transcriptomic sequencing was performed. RNA sequencing data from neuronal exosomes isolated from serum showed mRNA transcripts of several neuronal genes. In particular, mRNAs of several olfactory receptor genes were present at elevated concentrations in the neuronal exosomes. Some of these genes were OR10A6, OR14A2, OR6F1, OR1B1, and OR1L1. RNA sequencing data from exosomes isolated from CSF showed a similar elevation of these olfactory receptors. We further validated the expression of these samples in serum samples of mild TBI patients, and a similar up-regulation of these olfactory receptors was observed. The data from these experiments suggest that damage to the neurons in the olfactory neuroepithelium as well as in the brain following a TBI may cause the release of mRNA from these receptors in the exosomes. Hence, olfactory receptors can be further explored as biomarkers for the diagnosis of TBI.

Indexed as

Brain ConcussionBrain InjuriesBrain Injuries, TraumaticExtracellular VesiclesOlfactory Receptor NeuronsReceptors, OdorantBiomarkersGene Expression ProfilingHumansRNARNA, MessengerBiomarkersReceptors, OdorantRNARNA, Messengerbiomarkersexosomestraumatic brain injury

Identifiers

PMID38474024
PMCPMC10931597
OpenAlexW4392234479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.